Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia
Abstract
Value Health. 2020;23(10):1292-1299.
DOI of original article: https://doi.org/10.1016/j.jval.2020.05.019
Portions of the Article and Author Information section (namely the author contributions, conflict of interest disclosures, funding/support, role of funder, and acknowledgement statements) that were published with this paper were for a different article. This article appears correctly online.
Authors